Introduction
============

Severe sepsis remains one of the most threatening conditions in intensive care. During the progression of sepsis from early hit to multiorgan failure proinflammatory and anti-inflammatory cytokines are released. Cytokines can be used as biomarkers to determine the specific patterns of sepsis progression and association with mortality \[[@B1]\]. These biomarkers were successfully used as predictors in animal studies \[[@B2]\]. Data from humans, especially comparison between children and adults, are limited. Hence, in this study we widely describe systemic cytokine response in this type of patient population.

Methods
=======

Prospective study of 37 subjects (20 children, 17 adults) hospitalized with severe sepsis in intensive care. We measured CRP, procalcitonin, TNF, IL-1β, IL-4, IL-6, IL-8, IL-10, IL-12, TREM-1. ANOVA models were specified using Proc Mixed. Study was fully approved by an ethics committee.

Results
=======

We identified a correlation of CRP levels with mortality or presence of shock (Figure [1](#F1){ref-type="fig"}). We found a distinct feature of CRP in adults with pronounced dynamic dichotomy in these subjects. Levels of IL-6 were significantly different in adult patients in the context of shock states. High IL-6 levels in the beginning of sepsis were associated with shock during progression of illness. Highest risk of death was in adult patients associated with TREM-1 sustained high after 48 hours after sepsis onset (Figure [2](#F2){ref-type="fig"}). Otherwise, there was no correlation with death, shock states and SOFA score for PCT, TNF, IL-1β, IL-4, IL-8, IL-10, and IL-12.

![**SOFA adults**. Solid line, SOFA 0 to 12; dashed line, SOFA 13 to 24.](cc8269-1){#F1}

![**Adults**. Solid line, exitus; dashed line, survived.](cc8269-2){#F2}

Conclusions
===========

Response of circulating factors in patients with severe sepsis is heterogeneous in the adult and children population and has some distinct features according to the dynamics of CRP, IL-6 and TREM-1.
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